Epidemiological Typing of Uropathogenic Pseudomonas Aeruginosa Strains from Hospitalized Patients
Overview
Infectious Diseases
Authors
Affiliations
One hundred and twenty-one clinical isolates of Pseudomonas aeruginosa from patients with hospital-acquired urinary tract infections (UTIs) were studied to determine their major epidemiological markers, including API 20NE profile, O-serotype, pyocin type, phage type, lysogenic state and antibiotic susceptibility. Serotypes O4, O12, O11, O6 and O5 were found with a high frequency, accounting respectively for 23.9%, 23.1%, 12.3%, 8.2% and 5.7% of isolates. Pyocin type 10 was most common (32.2%) followed by types 1 (10.7%), 33 (7.5%) and 105 (4.1%); subtype h was predominant being characteristic of 34.7% of isolates. Most of the strains (69.4%) were either not phage typable or sensitive to phages 68 and 119x. Resistance to gentamicin, tobramycin, amikacin, imipenem and ciprofloxacin was more frequent among strains belonging to serotype O12. The O-serotypes were combined with API 20NE profiles, pyocin and phage types, lysogenic states and antibiotic resistance in order to identify epidemiologically related clones. Within predominant serotypes--O4 and O12--most strains displayed similar but not identical type characteristics, whereas other serotypes were less homogeneous. Our results support the concept that a combination of current typing techniques allows the identification of epidemiologically related P. aeruginosa isolates.
Urinary tract infections and catheter-associated urinary tract infections caused by .
El Husseini N, Carter J, Lee V Microbiol Mol Biol Rev. 2024; 88(4):e0006622.
PMID: 39431861 PMC: 11653733. DOI: 10.1128/mmbr.00066-22.
EVALUATION OF HOSPITAL ACQUIRED PSEUDOMONAS INFECTION IN PARAPLEGIC AND ORTHOPAEDIC CASES.
Lahiri K Med J Armed Forces India. 2017; 54(1):23-26.
PMID: 28775405 PMC: 5531207. DOI: 10.1016/S0377-1237(17)30401-X.
Tassios P, Gennimata V, Maniatis A, Fock C, Legakis N J Clin Microbiol. 1998; 36(4):897-901.
PMID: 9542905 PMC: 104657. DOI: 10.1128/JCM.36.4.897-901.1998.
In vitro activity of commercially manufactured disinfectants against Pseudomonas aeruginosa.
Orsi G, Tomao P, Visca P Eur J Epidemiol. 1995; 11(4):453-7.
PMID: 8549714 DOI: 10.1007/BF01721232.
Characteristics of Pseudomonas aeruginosa strains isolated from urinary tract infections.
PUZOVA H, Siegfried L, Kmetova M, Durovicova J, Kerestesova A Folia Microbiol (Praha). 1994; 39(4):337-41.
PMID: 7729771 DOI: 10.1007/BF02814324.